# Daniel Castellano, M.D. – FDA Inspection, Nov 15, 2024

Source: https://www.keypedia.com/records/fda_inspections/daniel-castellano-md/489b00af-69f0-47f8-9b1c-b54e53bc673d
Source feed: FDA_Inspections

> FDA inspection 1257521 of Daniel Castellano, M.D., November 15, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257521
- Company Name: Daniel Castellano, M.D.
- Inspection Date: 2024-11-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/jeanne-j-thai/f7b057a4-ab4c-43de-a448-384ff9f8598f)

Company: https://www.keypedia.com/companies/daniel-castellano-md/5a45af56-2069-4936-837d-d9d9d5235f40

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c